Form 8-K - Current report:
SEC Accession No. 0001104659-21-004908
Filing Date
2021-01-19
Accepted
2021-01-19 06:09:10
Documents
12
Period of Report
2021-01-13
Items
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm213443d1_8k.htm   iXBRL 8-K 24850
  Complete submission text file 0001104659-21-004908.txt   198332

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cyrx-20210113.xsd EX-101.SCH 3187
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cyrx-20210113_lab.xml EX-101.LAB 34592
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cyrx-20210113_pre.xml EX-101.PRE 22711
5 EXTRACTED XBRL INSTANCE DOCUMENT tm213443d1_8k_htm.xml XML 3591
Mailing Address 112 WESTWOOD PLACE, SUITE 350 BRENTWOOD TN 37027
Business Address 112 WESTWOOD PLACE, SUITE 350 BRENTWOOD TN 37027 (949) 232-1900
Cryoport, Inc. (Filer) CIK: 0001124524 (see all company filings)

EIN.: 880313393 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34632 | Film No.: 21533738
SIC: 2834 Pharmaceutical Preparations